Investor Presentation
Investor Presentation
Perth, Feb 27, 2018 AEST (ABN Newswire) - MMJ PhytoTech Limited (ASX:MMJ) ("MMJ" or "the Company") is pleased to attach an investor presentation and speaker notes to be presented by the Company's Chief Executive Officer Jason Conroy today in Sydney at the Finance News Network Investor Event.

Speaker Notes

Good morning.

My name is Jason Conroy and I am, as of yesterday, the new CEO of MMJ.

As we announced on 19 February, I have replaced Andreas Gedeon who has retired as CEO and Managing Director to devote his time and energy to growing Harvest One, which is currently MMJ's largest investment.

I am new to the cannabis sector.

My most recent experience was as CFO of an ASX100 group where I managed a portfolio of energy infrastructure companies for nine years.

As part of that role I was responsible for M&A, recapitalisations and restructuring which led to the group being acquired at an attractive valuation.

So I definitely bring a new perspective and set of skills to managing and building MMJ's portfolio of investments.

With this fresh set of eyes I am very excited to lead MMJ into the next phase of its growth.

So turning now to the presentation and we start on slide 2.

Slide 2: Investment Strategy

MMJ's investment strategy is clear.

We are focused on building a diversified portfolio of cannabis sector investments.

MMJ owns a portfolio of five investments and we see scope to further grow and develop this portfolio over the next few years.

We differentiate ourselves from a number of other ASX listed entities in the sector by focusing our attention on Canada.

Why? Because Canada is expected to legalise its recreational market in mid to late this year, opening up a potential multi billion-dollar market opportunity for companies like those in MMJ's portfolio.

Similar to a private equity investor, we will take an active management approach to exiting, merging or diluting ownership positions where it adds value for our shareholders.

Our future focus is to create opportunities for MMJ's shareholders to benefit from our due diligence and participate in the growth of a diversified group of privately held minority investments.

My background and experience, complemented by the corporate finance and legal experience of MMJ's board, positions us well to capture, manage and optimise future investment opportunities.

Slide 3: Current Investment Portfolio

MMJ's investment portfolio is summarised on slide 3.

Our investments are diversified across the cannabis value chain.

The core investment in our portfolio is Harvest One, a TSX-V listed company in which MMJ holds over 53 million shares representing a significant minority shareholding of around 34%.

With recent capital raisings, Harvest One has a cash balance of around C$80 million to fund its growth initiatives with a focus on expanding its cannabis production facilities.

MMJ is satisfied with the level of its investment in Harvest One and expects its shareholding to be progressively diluted as Harvest One raises capital in the future to fund growth initiatives and as various convertible instruments are exchanged for ordinary shares.

WeedMe and Dosecann are MMJ's most recent investments, with each focused on the Canadian market.

With WeedMe we are aiming to replicate the business model and success of Harvest One.

With Dosecann we are backing an experienced management team that is focusing on extraction facilities and on developing new products.

I aim to present and discuss the outlook of MMJ's investments in more detail once I have met each of the management teams in the next few months.

Slide 4: Canadian Market Opportunity

I am now on slide 4.

As I have already mentioned, we see Canada as a very attractive market for MMJ's investments.

Canada is expected to be the largest federal jurisdiction in the world to legalise cannabis consumption.

The total legalised market opportunity is estimated by Deloitte to exceed $20 billion.

Moving to slide 5.

Slide 5: Canadian Licensed Producers

In my opinion, one of the most fascinating and exciting developments is the level of Canadian public market investor interest in the sector and the emergence of consolidation by the larger players.

Looking at the table, on a comparable basis we see significant upside from our investment in Harvest One as it moves to deliver its funded capacity.

Slide 6: Contact Details

That concludes my presentation and I thank you for your attention and interest in MMJ.

To view the presentation, please visit:
http://abnnewswire.net/lnk/5PH8ZR91


About MMJ PhytoTech Ltd

Phytotech Medical ASX:PYL

In October 2017, MMJ PhytoTech Limited (ASX:MMJ) announced its strategy to become an incubator for strategic investments across regulated jurisdictions globally covering the entire cannabis value chain.

Following the successful listing of United Greeneries Holdings Ltd ("United Greeneries") and Satipharm AG ("Satipharm") on the TSX-V through Harvest One Cannabis Inc. (CVE:HVT), MMJ has focused on the identification of a number of independent strategic investment opportunities that have the potential to deliver significant value to the Company's shareholders.

MMJ is actively pursuing early stage opportunities with the ability to deliver significant future revenue and the opportunity to provide dramatic global synergistic value as regulatory frameworks in key international markets continue to evolve. MMJ is targeting the full range of emerging cannabis-related sectors including healthcare products, technology, infrastructure, logistics, processing, cultivation, equipment, R&D, hemp food products and retail.

MMJ currently holds an equity stake of 53,333,333 shares in Harvest One, 100% ownership of Israeli-based R&D division PhytoTech Therapeutics Limited ("PTL") and strategic holdings in e-Sense Lab Limited (ASX:ESE) and private Canadian-based company WeedMe Inc.

      


Contact

Investor Enquiries:
Jason Conroy
Chief Executive Officer
E: info@mmjphytotech.com.au

Media Enquiries:
Sam Burns
Six Degrees Investor Relations
M: +61-400-164-067



Related Companies

MMJ PhytoTech Ltd   

ABN Newswire This Page Viewed:  (Last 7 Days: 51) (Last 30 Days: 387) (Since Published: 1726) 
ANALYTICS: LOGIN HERE

MMJ PhytoTech Ltd NEWS: RECENT VISITS (22072)

Research Report

Social Media